Skip to content

Dicerna Pharmaceuticals Inc

CIK 0001399529

← back to feed
Revenue (TTM)
$200.77M
+2,220.7% YoY Q3 Nov 2021
Net Income (TTM)
−$109.7M
−184.2% YoY Q3 Nov 2021
EPS Diluted (TTM)
−$1.43
Q3 Nov 2021
Gross Margin
—
Q3 Nov 2021
Operating Margin
-56.0%
Q3 Nov 2021
Net Margin
-54.6%
Q3 Nov 2021
Free Cash Flow (TTM)
$343.05M
Q3 Nov 2021
Cash
$165.76M
Q3 Nov 2021
Total Debt
$4.05M
Q3 Nov 2021
Shares Outstanding
77.89M sh
Q3 Nov 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings